BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 21108436)

  • 1. Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors.
    Eaton KW; Tooke LS; Wainwright LM; Judkins AR; Biegel JA
    Pediatr Blood Cancer; 2011 Jan; 56(1):7-15. PubMed ID: 21108436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-density single nucleotide polymorphism array analysis in patients with germline deletions of 22q11.2 and malignant rhabdoid tumor.
    Jackson EM; Shaikh TH; Gururangan S; Jones MC; Malkin D; Nikkel SM; Zuppan CW; Wainwright LM; Zhang F; Biegel JA
    Hum Genet; 2007 Sep; 122(2):117-27. PubMed ID: 17541642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rhabdoid tumor predisposition syndrome caused by SMARCB1 constitutional deletion: prenatal detection of new case of recurrence in siblings due to gonadal mosaicism.
    Gigante L; Paganini I; Frontali M; Ciabattoni S; Sangiuolo FC; Papi L
    Fam Cancer; 2016 Jan; 15(1):123-6. PubMed ID: 26342593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-resolution genomic analysis suggests the absence of recurrent genomic alterations other than SMARCB1 aberrations in atypical teratoid/rhabdoid tumors.
    Hasselblatt M; Isken S; Linge A; Eikmeier K; Jeibmann A; Oyen F; Nagel I; Richter J; Bartelheim K; Kordes U; Schneppenheim R; Frühwald M; Siebert R; Paulus W
    Genes Chromosomes Cancer; 2013 Feb; 52(2):185-90. PubMed ID: 23074045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic analysis using high-density single nucleotide polymorphism-based oligonucleotide arrays and multiplex ligation-dependent probe amplification provides a comprehensive analysis of INI1/SMARCB1 in malignant rhabdoid tumors.
    Jackson EM; Sievert AJ; Gai X; Hakonarson H; Judkins AR; Tooke L; Perin JC; Xie H; Shaikh TH; Biegel JA
    Clin Cancer Res; 2009 Mar; 15(6):1923-30. PubMed ID: 19276269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-linkage of familial rhabdoid tumors to SMARCB1 implies a second locus for the rhabdoid tumor predisposition syndrome.
    Frühwald MC; Hasselblatt M; Wirth S; Köhler G; Schneppenheim R; Subero JI; Siebert R; Kordes U; Jürgens H; Vormoor J
    Pediatr Blood Cancer; 2006 Sep; 47(3):273-8. PubMed ID: 16206192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conventional chondrosarcoma in a survivor of rhabdoid tumor: enlarging the spectrum of tumors associated with SMARCB1 germline mutations.
    Forest F; David A; Arrufat S; Pierron G; Ranchere-Vince D; Stephan JL; Clemenson A; Delattre O; Bourdeaut F
    Am J Surg Pathol; 2012 Dec; 36(12):1892-6. PubMed ID: 23154773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rhabdoid tumor predisposition syndrome.
    Sredni ST; Tomita T
    Pediatr Dev Pathol; 2015; 18(1):49-58. PubMed ID: 25494491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent hSNF5/INI1 germline mutations in patients with rhabdoid tumor.
    Bourdeaut F; Lequin D; Brugières L; Reynaud S; Dufour C; Doz F; André N; Stephan JL; Pérel Y; Oberlin O; Orbach D; Bergeron C; Rialland X; Fréneaux P; Ranchere D; Figarella-Branger D; Audry G; Puget S; Evans DG; Pinas JC; Capra V; Mosseri V; Coupier I; Gauthier-Villars M; Pierron G; Delattre O
    Clin Cancer Res; 2011 Jan; 17(1):31-8. PubMed ID: 21208904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term survival and transmission of INI1-mutation via nonpenetrant males in a family with rhabdoid tumour predisposition syndrome.
    Ammerlaan AC; Ararou A; Houben MP; Baas F; Tijssen CC; Teepen JL; Wesseling P; Hulsebos TJ
    Br J Cancer; 2008 Jan; 98(2):474-9. PubMed ID: 18087273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
    Kohashi K; Izumi T; Oda Y; Yamamoto H; Tamiya S; Taguchi T; Iwamoto Y; Hasegawa T; Tsuneyoshi M
    Hum Pathol; 2009 Mar; 40(3):349-55. PubMed ID: 18973917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors.
    Biegel JA; Tan L; Zhang F; Wainwright L; Russo P; Rorke LB
    Clin Cancer Res; 2002 Nov; 8(11):3461-7. PubMed ID: 12429635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SMARCB1 mutations in schwannomatosis and genotype correlations with rhabdoid tumors.
    Smith MJ; Wallace AJ; Bowers NL; Eaton H; Evans DG
    Cancer Genet; 2014 Sep; 207(9):373-8. PubMed ID: 24933152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide approach to identify second gene targets for malignant rhabdoid tumors using high-density oligonucleotide microarrays.
    Takita J; Chen Y; Kato M; Ohki K; Sato Y; Ohta S; Sugita K; Nishimura R; Hoshino N; Seki M; Sanada M; Oka A; Hayashi Y; Ogawa S
    Cancer Sci; 2014 Mar; 105(3):258-64. PubMed ID: 24418192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predisposition to atypical teratoid/rhabdoid tumor due to an inherited INI1 mutation.
    Janson K; Nedzi LA; David O; Schorin M; Walsh JW; Bhattacharjee M; Pridjian G; Tan L; Judkins AR; Biegel JA
    Pediatr Blood Cancer; 2006 Sep; 47(3):279-84. PubMed ID: 16261613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Favorable outcome of patients affected by rhabdoid tumors due to rhabdoid tumor predisposition syndrome (RTPS).
    Kordes U; Bartelheim K; Modena P; Massimino M; Biassoni V; Reinhard H; Hasselblatt M; Schneppenheim R; Frühwald MC
    Pediatr Blood Cancer; 2014 May; 61(5):919-21. PubMed ID: 24123847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly aggressive behavior of malignant rhabdoid tumor: a special reference to SMARCB1/INI1 gene alterations using molecular genetic analysis including quantitative real-time PCR.
    Kohashi K; Oda Y; Yamamoto H; Tamiya S; Izumi T; Ohta S; Taguchi T; Suita S; Tsuneyoshi M
    J Cancer Res Clin Oncol; 2007 Nov; 133(11):817-24. PubMed ID: 17486366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital anomalies and rhabdoid tumor associated with 22q11 germline deletion and somatic inactivation of the SMARCB1 tumor suppressor.
    Toth G; Zraly CB; Thomson TL; Jones C; Lapetino S; Muraskas J; Zhang J; Dingwall AK
    Genes Chromosomes Cancer; 2011 Jun; 50(6):379-88. PubMed ID: 21412926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors.
    Biegel JA; Zhou JY; Rorke LB; Stenstrom C; Wainwright LM; Fogelgren B
    Cancer Res; 1999 Jan; 59(1):74-9. PubMed ID: 9892189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel germ-line deletion of SNF5/INI1/SMARCB1 gene in neonate presenting with congenital malignant rhabdoid tumor of kidney and brain primitive neuroectodermal tumor.
    Kusafuka T; Miao J; Yoneda A; Kuroda S; Fukuzawa M
    Genes Chromosomes Cancer; 2004 Jun; 40(2):133-9. PubMed ID: 15101046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.